Sarah Alwardt

In her 10 years at Avalere, Carpenter led the firm’s consulting, sales and operational teams through a period of substantial growth for the firm and significant changes in the healthcare landscape. She will join PhRMA as executive vice president of policy and research.

Jennifer Richman, imre

Industry veteran Jennifer Richman has been appointed executive vice president of client operations and will be responsible for helping amplify, grow, and scale the operations department as the agency continues its forward momentum, taking on more healthcare client work.

Syneos Health

“Our people are the foundation to being the solutions partner of choice to the biopharmaceutical industry,” said Michelle Keefe, CEO, Syneos Health. “Hillary is a proven leader who brings a forward-thinking approach to talent development. She’ll play an instrumental role in transformation, executing our people strategy and building an inclusive culture.”

Jay Carter

After more than three decades and an accomplished career at AbelsonTaylor, Jay Carter is not throwing in the towel; he’s making a move to JUICE Pharma. The agency is ramping up for a new chapter of growth and Carter just may be the last piece in the growth module that they’re formulating. Stay tuned.

Doable

Consumers-with-disabilities research business also launches alongside agency.

Eric Densmore, AbelsonTaylor

The agency will expand business development capabilities with advanced data-driven approaches and ‘return on imagination’.

i-one lung

Four world-renowned oncologists selected 20 key, non-small cell lung cancer (NSCLC) abstracts presented at the American Society of Clinical Oncology (ASCO) annual conference. Their goal is to use their platform as educators to share unbiased perspectives on the studies’ clinical data, the methodologies, and its potential for improving patient outcomes in lung cancer.

Mary Rose Burnham, Greater Than One

Burnham will be responsible for overseeing the partnership of brand and medical strategists on each of Greater Than One’s accounts, to build better healthcare experiences for customers.

HCP-patient relationship

The healthcare industry will face unique challenges in targeting healthcare providers (HCPs) without the support of third-party cookies. The removal of these cookies particularly impacts remarketing campaigns and audience data analysis. Despite these hurdles, the pharmaceutical industry is well-positioned to navigate this change due to its experience in working within strict privacy and regulatory frameworks. This article explores the specific implications of a cookie-less future on HCP targeting, delving into effective strategies, solutions, and best practices to effectively engage with this critical audience segment while prioritizing data privacy.

21GRAMS is helping Moons, a company that sells period products, in its goal to make menstruation a more positive experience for menstruators by giving them a role in stem cell research.